Tag Archives: FDA

Sweeteners: Artificial or Natural – Which is Sweetest & Lowest in Calorie

High-intensity sweeteners are commonly used as alternatives to sugar because they are many times sweeter than sugar but contribute only a few to no calories when added to foods. High-intensity sweeteners, like all other ingredients added to are found to be safe for consumption by UD FDA or EFSA. SaccharinSaccharin is a non-nutritive sweetener, which means that […]

Aspirin Not Useful in Primary Prevention of Heart Attack, CV Disease or Stroke

Heart attack, stroke

  U.S. Food and Drug Administration (FDA) has published a consumer update regarding usage of Aspirin in patients with and without previous heart disease and stroke. Scientific evidence has shown that daily Aspirin can help in prevention heart attack and Stroke in some patients but not all. Aspirin should only be taken after the advice […]

FDA Allows Marketing of First Prosthetic Arm dubbed “Luke”

  The U.S. Food and Drug Administration (FDA) today allowed marketing of the DEKA Arm System, the first prosthetic arm that can perform multiple, simultaneous powered movements controlled by electrical signals from electromyogram (EMG) electrodes. This is the first time FDA has allowed marketing of a prosthetic arm. Functioning of the prosthesis is by determining […]

FDA Approves Vedolizumab to Treat Ulcerative Colitis & Crohn’s Disease

us food and drug administration

  The U.S. Food and Drug Administration (FDA) approved new drug Entyvio (vedolizumab) for the treatment of moderate to severe ulcerative colitis and Crohn’s disease. Vedolizumab is given injectable form. FDA has approved its use in patients with ulcerative colitis or Crohn’s disease in whom one or more o standard therapies like corticosteroids, immunomodulators or […]

FDA Approves Dalbavancin to Treat Adult Skin Infections

us food and drug administration

  The U.S. Food and Drug Administration approved a new antibacterial drug Dalvance (dalbavancin) for use in the treatment of adult skin infections. Dalbavancin is intended to treat Acute Bacterial Skin and Skin Structure Infections (ABSSSI). ABSSSI is caused by certain susceptible bacteria like Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains) and Streptococcus pyogenes. The […]

FDA Approves Device for Treatment of Restless Leg Syndrome

us food and drug administration

The US Food and Drug Administration (FDA) has approved a new device which  is used in improving quality of sleep in patients with primary Restless Leg Syndrome (RLS). The announcement of approval has been done by the company on its website. The device name is “Relax” which has been made by Sensory Medical Inc. The […]

FDA Lowers Recommended Starting Dose of Lunesta (Eszopiclone)

us food and drug administration

The U.S. Food and Drug Administration (FDA) has issued a warning regarding the use of drug Lunesta (Eszopiclone) which is used in the treatment of insomnia. Lunesta (Eszopiclone) is a sedative-hypnotic type of drug used to treat insomnia. The warning comes after a study on Lunesta showed that higher doses of Lunesta taken at bedtime […]